Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-08
2010-02-09
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356500
Reexamination Certificate
active
07659297
ABSTRACT:
The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I)process for their production and their use as antiinflammatory agents.
REFERENCES:
patent: 3907879 (1975-09-01), Murakami et al.
patent: 5059609 (1991-10-01), Eggler et al.
patent: 5112834 (1992-05-01), Senn-Bilfinger
patent: 5446069 (1995-08-01), Shih et al.
patent: 5489584 (1996-02-01), Vuligonda et al.
patent: 6197783 (2001-03-01), Senn-Bilfinger et al.
patent: 6897224 (2005-05-01), Jaroch et al.
patent: 7348322 (2008-03-01), Gong et al.
patent: 2003/0199690 (2003-10-01), Dahanukar et al.
patent: 2005/0090559 (2005-04-01), Berger
patent: 2005/0171109 (2005-08-01), Rehwinkel et al.
patent: 2005/0209324 (2005-09-01), Rehwinkel et al.
patent: 2005/0222154 (2005-10-01), Rehwinkel et al.
patent: 2005/0272823 (2005-12-01), Rehwinkel et al.
patent: 2006/0040933 (2006-02-01), Jaroch et al.
patent: 2006/0084652 (2006-04-01), Baeurle et al.
patent: 2006/0165915 (2006-07-01), Lietzau et al.
patent: 2006/0167025 (2006-07-01), Berger
patent: 2006/0202163 (2006-09-01), Lietzau et al.
patent: 2006/0229305 (2006-10-01), Berger et al.
patent: 2006/0247292 (2006-11-01), Rehwinkel et al.
patent: 2007/0015750 (2007-01-01), Baeurle et al.
patent: 2007/0015761 (2007-01-01), Mengel et al.
patent: 2007/0129359 (2007-06-01), Huwe et al.
patent: 2007/0225290 (2007-09-01), Berger et al.
patent: 2008/0153859 (2008-06-01), Rehwinkel et al.
patent: 15 24835 (2004-09-01), None
patent: 0 291 327 (1988-11-01), None
patent: 0291327 (1988-11-01), None
patent: 0 229 470 (1989-01-01), None
patent: 0299470 (1989-01-01), None
patent: 0 439 265 (1991-07-01), None
patent: 0439265 (1991-07-01), None
patent: 05 79223 (1994-01-01), None
patent: 63 220242 (1988-09-01), None
patent: 2000 256255 (2000-09-01), None
patent: WO 88 08836 (1988-11-01), None
patent: WO 96 20930 (1996-07-01), None
patent: WO 99 04778 (1999-02-01), None
patent: WO 99 06388 (1999-02-01), None
patent: WO 99 37607 (1999-07-01), None
patent: WO 99 50205 (1999-10-01), None
patent: WO 00 10977 (2000-03-01), None
patent: WO 01 30734 (2001-05-01), None
patent: WO 02 10143 (2002-02-01), None
patent: WO 02/16318 (2002-02-01), None
patent: WO 0216318 (2002-02-01), None
patent: WO 03 000694 (2003-01-01), None
patent: WO 03 027061 (2003-04-01), None
patent: WO 03 040107 (2003-05-01), None
patent: WO 03 045924 (2003-06-01), None
patent: WO 03 082280 (2003-10-01), None
patent: WO 03/082827 (2003-10-01), None
patent: WO 2004 020375 (2004-03-01), None
patent: WO 2004/063163 (2004-07-01), None
patent: WO 2004/075864 (2004-09-01), None
patent: WO 2005/003098 (2005-01-01), None
patent: WO 2005 021682 (2005-03-01), None
patent: WO 2006/027236 (2005-03-01), None
patent: WO 2005 034939 (2005-04-01), None
patent: WO 2005/090343 (2005-09-01), None
patent: WO 2006015870 (2006-02-01), None
patent: WO 2006/066950 (2006-06-01), None
patent: WO 2006 100100 (2006-09-01), None
patent: WO 2006/108699 (2006-10-01), None
patent: WO 2006/108714 (2006-10-01), None
Greene. Protective Groups in Organic Synthesis, 1999, pp. 17-23.
Warner-Lambert. Expert Opinion on Therapeutic Patents, 2000, 10 (1), 121-23.
Ehlert. Expert Opinion on Investigational Drugs, 2000, 9 (3), 627-629.
Office Action dated Oct. 3, 2007 in related U.S. Appl. No. 10/962,169, filed Oct. 12, 2004.
Office Action dated Oct. 2, 2007 in related U.S. Appl. No. 10/961,406, filed Oct. 12, 2004.
Office Action dated Apr. 24, 2007 in related U.S. Appl. No. 11/222,250, filed Sep. 9, 2005.
Int'l Search Report dated issued Jan. 18, 2006 in PCT/EP2005/009623.
Evans, D.A. et al., ,<21 C2-symmetric copper (II) complexes as chiral lewis acids. Catalytic enantioselective carbonyl-ene reactions with glyoxylate and pyruvate esters, >> Journal of the American Chemical Society, 2000, pp. 7936-7943, vol. 122, Washington, D.C.
Cleghorn, L.A.T. et al., “Three- component bimetallic (pd/In) mediated cascade allylation of C=X functionality—Part 1. Scope and class 1 examples with aldehydes and ketones,” Journal of Organometallic Chemistry, Dec. 7, 2003, pp. 483-493, vol. 687 No. 2, Elsevier-sequoia S.A. Lausanne, CH.
Wikipedia, Inflammation, p. 1-11.
Int'l Search Report dated issued Mar. 15, 2007 in PCT/EP2007/002432.
Database CA (Online), Chemical Abstracts Service, Coloumbus, OH, 2004. Patonay, Tamas et al., “Synthesis of racemic and enantiomerically enriched .alpha.-Oxyfunctionalized benzocyclanones and chromanones by dimethyldioxirane and dimethyldioxirane/Mn (III) salen system,” XP002397131.
Database CA (Online), Chemical Abstracts Service, Columbus, OH, 2001. Ferraz, Helenca et al., “The reaction of 1-tetralones with thallium trinitrate supported on clay: ring contraction vs. .alpha.-oxidation,” XP002397132.
Database CA (Online), Chemical Abstracts Service, Columbus, OH, 1994. Srivastava, J.N. et al., ,<< Synthesis of 7-methoxytatralino[3,4-c]isocumarins and 7-methoxy-and 6-methoxytatralino[3,4-c]isoquinolones, >> XP002397133.
Database CA (Online), Chemical Abstracts Service, Columbus, OH, 1983. Thiem, Joachim et al., “2,6-dideoxy sacchride glycosides of .alpha.-hydroxy ketones: synthesis and configurational assignment of glycosides with the tetralone substructure of olivomycin,” XP002397135.
Chemical Abstracts 138:385424, 138:287411, 143:193936, 141:218306, 140:357328, 134:326287, 134:71375, 126:34370, 89:42860.
Hachisu et al., Thiazolium ylide-catalyzed intramolecular aldehyde-ketone benzoin-forming reactions. Advanced Synthesis & Catalysis, 2004, col. 346 (9+10), pp. 1097-1100; HCAPLUS abstract, Doc. No. 142:260997.
Dehmolow et al. Monodeazacinchona Alkaloid Derivates : Synthesis and Preliminary Applications as Phase-Transfer Catalyst European Journal of Organic Chemistry, 2002 (13), pp. 2133-2136.
Nagau et al. New Ring-Expansion Reactions of Hydroxy Propenoyl Cyclic Compounds under Palladium (O)/Phosine-Catalyzed Conditions. Organic Letters, 2004, vol. 6 (13), pp. 2133-2136.
Greene. Protective Groups in Organic Sythesis, 1999, pp. 17-23.
Ene reaction, Wikipedia.
Noseworthy et al., The New England Journal of Medicine, p. 949, vol. 343, No. 13, (2005).
Jordan, V.C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dorwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Sucessful Synthesis Design, Weinheim: Wiley-VCH Verlag Gmbh & Co. KgaA, 2005, Preface.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20thedition, vol. 1m 1004-1010, 1996.
Smoak et al., Mechanism of Ageing and Development, 125 697-706, 2004.
Saklavala et al., Arthritis Research 4(3), 146-150, 2002.
Barnes, P.J., Eur. Respir. J., 27(2), 413-426, 2006.
Bellucci et al., Tetrahedron Asymmetry, 8, 895-902, 1997.
Tchilibon et al., Biochemical Pharmacology, 70 (2005), 381-393.
U.S. Appl. No. 10/962,169, filed Oct. 12, 2004—Non-Final Rejection mailed Oct. 3, 2007.
U.S. Appl. No. 10/962,169, filed Oct. 12, 2004—Final Rejection mailed Jul. 14, 2008.
U.S. Appl. No. 10/961,406, filed Oct. 12, 2004—Non-Final Rejection mailed Oct. 2, 2007.
U.S. Appl. No. 10/961,406, filed Oct. 12, 2004— Final Rejection mailed Jul. 14, 2008.
U.S. Appl. No. 11/222,250, filed Sep. 9, 2005—Non-Final Rejection mailed Apr. 24, 2007.
U.S. Appl. No. 11/222,250, filed Sep. 9, 2005—Final Rejection mailed Sep. 28, 2007.
U.S. Appl. No. 11/222,250, filed Sep. 9, 2005—Advisory Action mailed Feb. 22, 2008.
U.S. Appl. No. 11/222,250, filed Sep. 9, 2005—Non-Final Rejection mailed May 28, 2008.
U.S. Appl. No. 11/222,250, filed Sep. 9, 2005—Final Rejection mailed Jan. 9, 2009.
U.S. Appl. No. 11/717,782, filed Mar. 14, 2007—Non Final Rejection mailed Aug. 18, 2008.
Baeurle Stefan
Berger Markus
Jaroch Stefan
Krolikiewicz Konrad
Mengel Anne
Bayer Schering Pharma AG
Jarrell Noble
Millen White Zelano & Branigan P.C.
Wilson James O
LandOfFree
Tetrahydronaphthalene derivatives, process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydronaphthalene derivatives, process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydronaphthalene derivatives, process for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4164912